Bayer Pharma Partnership Announcement Expected By Year-End
Executive Summary
Bayer expects to announce a partnership for its pharmaceutical business by the end of the year, Board Chairman Werner Wenning told analysts during a discussion of first half results Aug. 1
You may also be interested in...
Bayer Sheds R&D Projects Ahead Of Joint Venture, Is Flexible On Control
Bayer is reducing the size of its R&D pipeline through product eliminations and outlicensing opportunities to maximize its influence over a future pharmaceutical partnership, Management Board Chairman Werner Wenning announced Nov. 12
Bayer Sheds R&D Projects Ahead Of Joint Venture, Is Flexible On Control
Bayer is reducing the size of its R&D pipeline through product eliminations and outlicensing opportunities to maximize its influence over a future pharmaceutical partnership, Management Board Chairman Werner Wenning announced Nov. 12
Bayer HealthCare CEO Classon To Seek Pharma Partner
One of the first responsibilities of incoming Bayer HealthCare CEO Rolf Classon will be to assist in seeking a pharmaceutical partner in time to announce a deal by the end of 2002